Decoding and unlocking the BCL-2 dependency of cancer cells, Nat Rev Cancer, vol.13, pp.455-65, 2013. ,
Why do BCL-2 inhibitors work and where should we use them in the clinic?, Cell Death Differ, vol.25, pp.56-64, 2018. ,
Efficacy of venetoclax as targeted therapy for relapsed/ refractory t(11;14) multiple myeloma, Blood, vol.130, pp.2401-2410, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-01631468
17beta-estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence, Mol Cell Biol, vol.20, pp.2890-901, 2000. ,
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups, Nature, vol.486, pp.346-52, 2012. ,
Sensitization of BCL-2-expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737, Proc Natl Acad Sci USA, vol.109, pp.2766-71, 2012. ,
,
Targeting BCL-2 with the BH3 mimetic ABT-199 in estrogen receptor-positive breast cancer, Cancer Cell, vol.24, pp.120-129, 2013. ,
The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized, Cancer Cell, vol.10, pp.389-99, 2006. ,
Breast cancer-associated fibroblasts: their roles in tumor initiation, progression and clinical applications, Front Med, vol.10, pp.33-40, 2016. ,
Prognostic stromal gene signatures in breast cancer, Breast Cancer Res BCR, vol.17, p.23, 2015. ,
Evolution of cancer stem-like cells in endocrineresistant metastatic breast cancers Is mediated by stromal microvesicles, Cancer Res, vol.77, pp.1927-1968, 2017. ,
Spatial proximity to fibroblasts impacts molecular features and therapeutic Sensitivity of breast cancer cells influencing clinical outcomes, Cancer Res, vol.76, pp.6495-506, 2016. ,
Carcinoma-associated fibroblasts: orchestrating the composition of malignancy, Genes Dev, vol.30, pp.1002-1021, 2016. ,
Differential impact of TGF-beta and EGF on fibroblast differentiation and invasion reciprocally promotes colon cancer cell invasion, Cancer Lett, vol.266, pp.263-74, 2008. ,
Choosing the right cell line for breast cancer research, Breast Cancer Res BCR, vol.13, p.215, 2011. ,
MCL-1 is a key determinant of breast cancer cell survival: validation of MCL-1 dependency utilizing a highly selective small molecule inhibitor, Mol Cancer Ther, vol.14, pp.1837-1884, 2015. ,
IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland, J Clin Invest, vol.117, pp.3988-4002, 2007. ,
Interleukin-6 acts as an antiapoptotic factor in human esophageal carcinoma cells through the activation of both STAT3 and mitogen-activated protein kinase pathways, Oncogene, vol.22, pp.7809-7827, 2003. ,
BH3 profiling as a tool to identify acquired resistance to venetoclax in multiple myeloma, Br J Haematol, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01353369
BH3 profiling in whole cells by fluorimeter or FACS, Methods San Diego Calif, vol.61, pp.156-64, 2013. ,
Designed BH3 peptides with high affinity and specificity for targeting Mcl-1 in cells, ACS Chem Biol, vol.9, pp.1962-1970, 2014. ,
BarilléNion S. ?-Secretase inhibition promotes cell death, Noxa upregulation, and sensitization to BH3 mimetic ABT-737 in human breast cancer cells, Breast Cancer Res BCR, vol.14, p.96, 2012. ,
Synergistic action of the MCL-1 inhibitor S63845 with current therapies in preclinical models of triple-negative and HER2-amplified breast cancer, Sci Transl Med, vol.9, 2017. ,
MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinib, Breast Cancer Res BCR, vol.18, p.125, 2016. ,
MCL-1 is a prognostic indicator and drug target in breast cancer, Cell Death Dis, vol.9, p.19, 2018. ,
c-Myc dependent expression of pro-apoptotic Bim renders HER2-overexpressing breast cancer cells dependent on antiapoptotic Mcl-1, Mol Cancer, vol.10, p.110, 2011. ,
IL-8 and TNF? levels correlate with disease stage in breast cancer patients, Adv Clin Exp Med Organ Wroclaw Med Univ, vol.26, pp.421-427, 2017. ,
Interleukin-6 receptor in spindle-shaped stromal cells, a prognostic determinant of early breast cancer, Tumour Biol J Int Soc Oncodev Biol Med, vol.37, pp.13377-84, 2016. ,
Aboussekhra A. The inflammatory/cancer-related IL-6/STAT3/NF-?B positive feedback loop includes AUF1 and maintains the active state of breast myofibroblasts, Oncotarget, vol.7, pp.41974-85, 2016. ,
Self-renewal of CD133(hi) cells by IL6/ Notch3 signalling regulates endocrine resistance in metastatic breast cancer, Nat Commun, vol.7, p.10442, 2016. ,
BCL-XL directly modulates RAS signalling to favour cancer cell stemness, Nat Commun, vol.8, p.1123, 2017. ,
Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis, Sci Transl Med, vol.9, 2017. ,
Therapeutic effects of deleting cancerassociated fibroblasts in cholangiocarcinoma, Cancer Res, vol.73, pp.897-907, 2013. ,
The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models, Nature, vol.538, pp.477-82, 2016. ,
Fibroblast heterogeneity and immunosuppressive environment in human breast cancer, Cancer Cell, vol.33, pp.463-479, 2018. ,
Significant impact of survivin on myeloma cell growth, Leukemia, vol.21, pp.1070-1078, 2007. ,
Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response, Breast Cancer Res BCR, vol.17, p.43, 2015. ,
Inferring tumour purity and stromal and immune cell admixture from expression data, Nat Commun, vol.4, p.2612, 2013. ,
, Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours, Nature, vol.490, pp.61-70, 2012.